澳大利亚和新西兰ICU过去30年关键诊断组死亡率趋势
该研究为回顾性队列研究,纳入1993年1月至2022年12月澳大利亚和新西兰209个ICU的2,838,654例成人(≥16岁)患者。与第一个十年相比,最后十年患者更老(60.0岁[18.2岁] vs. 62.0岁[17.8岁])、至少一种主要合并症更多(23.2% vs. 25.2%)、APACHE III评分更高(45.6[28.1] vs. 50.9[24.1])。死亡率最高的五个诊断组为心脏骤停(53.6%)、卒中及颅内出血(34.8%)、蛛网膜下腔出血(21.2%)、肺炎(19.2%)和脓毒症(19%)。风险校正死亡率至2010年下降后趋于平台;心脏骤停风险校正死亡率改善最大(第三 vs. 第一个十年OR 0.82 [0.81-0.83]),肺炎改善最小(OR 0.87 [0.87-0.88]);卒中及颅内出血死亡率持续改善,而心脏骤停死亡率近10年似有上升。作者认为平台原因需进一步调查。
要点
- 心脏骤停、卒中及颅内出血、蛛网膜下腔出血、肺炎、脓毒症是死亡率最高的五个诊断组,死亡率分别为53.6%、34.8%、21.2%、19.2%、19%。
- 风险校正死亡率至2010年下降后趋于平台;心脏骤停第三 vs. 第一个十年OR 0.82(0.81-0.83),肺炎OR 0.87(0.87-0.88)。
- 卒中及颅内出血风险校正死亡率持续改善,而心脏骤停死亡率近10年似有上升。
- 最后十年患者较第一个十年更老(62.0岁[17.8岁] vs. 60.0岁[18.2岁])、合并症更多(25.2% vs. 23.2%)、APACHE III评分更高(50.9[24.1] vs. 45.6[28.1])。
- 作者认为风险校正死亡率改善趋于平台的原因需进一步调查。
适用人群与场景
- 1993年1月至2022年12月澳大利亚和新西兰所有向ANZICS APD贡献数据的ICU中,年龄≥16岁的成人患者。
研究设计与关键结果
- 研究类型为回顾性队列研究;最终队列纳入209个ICU的2,838,654例患者;无干预。
- 与第一个十年相比,最后十年患者年龄60.0岁(18.2岁)vs. 62.0岁(17.8岁),至少一种主要合并症23.2% vs. 25.2%,APACHE III评分45.6(28.1)vs. 50.9(24.1)。
- 死亡率最高的五个诊断组:心脏骤停53.6%、卒中及颅内出血34.8%、蛛网膜下腔出血21.2%、肺炎19.2%、脓毒症19%。
- 风险校正死亡率至2010年下降后趋于平台;心脏骤停第三 vs. 第一个十年OR 0.82(0.81-0.83),肺炎OR 0.87(0.87-0.88)。
- 大多数诊断组改善模式相似;卒中及颅内出血死亡率持续改善,而心脏骤停死亡率近10年似有上升。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为过去30年ICU风险校正死亡率显著改善但近期趋于平台,平台原因需进一步调查。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The Australia and New Zealand Intensive Care Society (ANZICS) Adult Patient Database (APD) has been operational for 3 decades. It is important to understand how mortality outcomes have changed across diagnostic groups over time to facilitate the planning of future healthcare resources. We evaluated the trends in risk-adjusted mortality for ICU patients over the last 30 years.
DESIGN: A retrospective cohort study.
SETTING: All ICUs in Australia and New Zealand that contributed data to the ANZICS APD from January 1993 to December 2022.
PATIENTS: Adult patients (≥ 16 yr) admitted to Australian and New Zealand ICUs.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: The final cohort included 2,838,654 patients from 209 ICUs. Compared with the first decade patients admitted during the final decade of the study were older (60.0 yr [18.2 yr] vs. 62.0 yr [17.8 yr]), more often had a least one major comorbidity (23.2% vs. 25.2%), and had higher Acute Physiology and Chronic Health Evaluation III scores (45.6 [28.1] vs. 50.9 [24.1]). The five diagnostic groups with the highest mortality rates were cardiac arrest (53.6%), stroke and intracranial hemorrhage (34.8%), subarachnoid hemorrhage (21.2%), pneumonia (19.2%), and sepsis (19%). Risk-adjusted mortality decreased until 2010 but then plateaued. Cardiac arrest saw the greatest improvement in risk-adjusted mortality between the third vs. first study decades (odds ratio [OR], 0.82 [0.81-0.83]), while pneumonia saw the least (OR, 0.87 [0.87-0.88]). The pattern of improvement for most diagnostic groups were similar; however, mortality from stroke and intracranial hemorrhage continued to improve, whereas mortality from cardiac arrest appears to have increased over the past 10 years.
CONCLUSIONS: There have been substantial improvements in risk-adjusted mortality among ICU patients over the past 30 years; however, this improvement has plateaued recently. The reasons for this plateau warrant further investigation.
参考来源
- Pilowsky JK, Ueno R, McLarty J, et al. Mortality Trends Across Key Diagnostic Groups in Australian and New Zealand ICUs Over the Past 30 Years. Crit Care Med. 2025. PMID: 40810586. doi:10.1097/CCM.0000000000006817
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。